Pancreatic Cancer Clinical Trials

Showing 721-740 of 1,019 trials

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors

NCT02403271

This is a Phase 1b/2, multi-center study to assess the safety and efficacy of ibrutinib in combination with durvalumab (MEDI4736) in participants with relapsed or refractory solid tumors.

Non-Small Cell Lung CancerBreast CancerPancreatic Cancer

Pharmacyclics LLC.124 participantsStarted Mar 2015

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • La Jolla, California, United States +14 more locations

COMPLETEDPhase 1

CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT01839981

This pilot clinical trial studies 6,8-bis(benzylthio)octanoic acid in treating patients with locally advanced or metastatic pancreatic cancer. Drugs used in chemotherapy, such as 6,8-bis(benzylthio)octanoic acid, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more

Wake Forest University Health Sciences10 participantsStarted Jul 2013

Winston-Salem, North Carolina, United States

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors

CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Related Searches

Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer

Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer

A Real-world Study of Albumin-bound Paclitaxel in the Treatment of Pancreatic Cancer

Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Impact of Three-dimensional Visualization on Operation Strategy and Complications for Pancreatic Cancer

hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer

Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer

A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer

PERiX: Comparison of Efficacy Between Placement of Epidural Catheters X-ray Guided and LOS Technique

Apatinib Combined With S-1 in the Second-line Treatment of Advanced Pancreatic Cancer

Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos

Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer

Pancreaticoduodenectomy in Elderly Pancreatic Ductal Adenocarcinoma Patients

TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors

Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life

Enhancing Fitness Before Pancreatic Surgery

Volatiles in Breath and Headspace Analysis - Diagnostic Markers